Galmed Pharmaceuticals Ltd.

GLMD | NASDAQ | 0 Followers
$1.78 +6.27% $0.10
Follow
Loading...

Profile

Galmed Pharmaceuticals Ltd. (GLMD) is a pharmaceutical company focused on the development of therapeutic therapies for conditions related to metabolic syndrome and liver diseases. The company concentrates on developing treatment approaches that can improve liver function and reduce the risk of complications associated with these diseases. Galmed Pharmaceuticals develops drugs for conditions such as non-alcoholic steatohepatitis (NASH) and other liver diseases. With the growing awareness of the importance of liver health and the need for effective treatment options, Galmed Pharmaceuticals Ltd. has the potential for sustained growth. Galmed Pharmaceuticals Ltd. (GLMD) shares might be an interesting choice for investors seeking involvement in the pharmaceutical therapies and liver disease treatment industry.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade